Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colonic Neoplasms 9Colorectal Neoplasms 6Stomach Neoplasms 3Rectal Neoplasms 3Pancreatic Neoplasms 3Adenomatous Polyposis Coli 3Esophageal Neoplasms 2Psychological Well-Being 1Neoplasm Metastasis 1Motor Activity 1Lung Neoplasms 1Gastritis, Atrophic 1Carcinoma 1Cachexia 1Adenocarcinoma 1

Interventions

Celecoxib 7Biopsy 5Sulindac 4Specimen Handling 3Eflornithine 3Curcumin 3guselkumab 2Ursodeoxycholic Acid 2Surveys and Questionnaires 2Sirolimus 2Sigmoidoscopy 2Gastroscopy 2Erythromycin 2Erlotinib Hydrochloride 2Endoscopy, Gastrointestinal 2Endoscopy, Digestive System 2Endoscopy 2Colonoscopy 2trifluridine tipiracil drug combination 1rofecoxib 1obeticholic acid 1Thiamine 1Surgical Procedures, Operative 1Suppositories 1Probiotics 1Polymorphism, Single-Stranded Conformational 1Polymerase Chain Reaction 1Pharmaceutical Preparations 1Oxaliplatin 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Adenomatous Polyposis Coli × Curcumin × Gastrointestinal × Clear all
NCT00927485 2020-12-16

Use of Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP)

University of Puerto Rico

Phase NA Completed
44 enrolled 7 charts
Gastrointestinal

Adenomatous Polyposis Coli

NCT00641147 2017-09-29

Curcumin in Treating Patients With Familial Adenomatous Polyposis

National Cancer Institute (NCI)

Phase 2 Completed
44 enrolled 23 charts
Gastrointestinal

Adenomatous Polyposis Coli

NCT00248053 2012-09-20

Use of Curcumin in the Lower Gastrointestinal Tract in Familial Adenomatous Polyposis Patients

Johns Hopkins University

Phase 2 Withdrawn
Gastrointestinal

Adenomatous Polyposis Coli

Data powered by HemOnc (CC BY 4.0) Colophon âš¡